FDA’s DTC Web Site For Consumers Sparks Congressional Investigations
Executive Summary
The pharmaceutical industry's effort to limit federal oversight of its advertising practices has become more difficult with revelations that an FDA Web site aimed at educating consumers was designed by a PR firm that has done work on drug product launches